ESAB Corp ESAB
Founded in 1904, ESAB Corporation ("ESAB," "we" or the "Company"), is a focused premier industrial compounder. ESAB provides its partners with fabrication technology advanced equipment, consumables, gas control equipment, robotics and digital solutions. The Company's rich history of innovative products and workflow solutions and our business management system, ESAB Business Excellence ("EBXai"), enables the Company's purpose of Shaping the world we imagineTM. We formulate, develop, manufacture and supply consumable products and equipment, including cutting, joining and welding robotics, as well as gas control equipment. Our products are marketed under several brand names, most notably ESAB, providing a wide range of products with innovative technologies to solve challenges in virtually any industry. Our sales channels include both independent distributors and direct salespeople that, depending on geography and end market, sell our products to our end users. ESAB is based in North Bethesda, Maryland and employs approximately 10,300 associates and serves customers in approximately 150 countries.
Valuation FY2025 figures against the last close
Where the revenue comes from as reported in the latest 10-K
Revenue by segment
- EMEA and APAC Segment
- Americas Segment
| Segment | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| EMEA and APAC Segment | $1.71B | $1.56B | $1.56B |
| Americas Segment | $1.13B | $1.18B | $1.21B |
As the company reported it, from the “Segment Information - Segment Reporting Information, by Segment (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Segments are the filer's own reporting structure, which is a decision about how it runs itself rather than a standard taxonomy: two companies in the same industry routinely divide themselves along different lines, so these are worth reading down a single company rather than across two. Slices under 1% are folded into “Other”.
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $2.84B | $2.74B | $2.77B | $2.59B | $2.43B | $1.95B | — |
| Cost of revenue | $1.79B | $1.70B | $1.76B | $1.71B | $1.59B | $1.27B | — |
| Gross profit | $1.05B | $1.04B | $1.02B | $885.5M | $838.0M | $682.5M | — |
| R&D | $44.0M | $39.2M | $38.8M | $36.0M | $39.7M | $34.8M | — |
| SG&A | $608.4M | $579.8M | $587.5M | $533.4M | $512.8M | $458.7M | — |
| Total operating expenses | $144.8M | $162.3M | $168.7M | $140.9M | — | — | — |
| Operating income | $412.2M | $447.4M | $404.2M | $329.1M | $306.2M | $202.1M | — |
| Pre-tax income | $328.3M | $370.4M | $319.1M | $300.3M | $319.1M | $205.8M | — |
| Income tax | $69.2M | $77.3M | $95.7M | $69.2M | $80.4M | $46.0M | — |
| Net income | $226.8M | $264.8M | $211.0M | $228.0M | $238.7M | $157.4M | — |
| EPS, basic | 3.71 | 4.36 | 3.39 | 3.70 | 3.92 | 2.62 | — |
| EPS, diluted | 3.67 | 4.31 | 3.36 | 3.69 | 3.92 | 2.62 | — |
| Shares, diluted (wtd. avg.) | 61.3M | 61.1M | 60.7M | 60.2M | 60.0M | 60.0M | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | $185.9M | $249.4M | $102.0M | $72.0M | $41.2M | $49.2M | $104.8M |
| Receivables | $451.3M | $370.3M | $385.2M | $374.3M | $383.5M | — | — |
| Inventory | $481.8M | $403.7M | $392.9M | $416.8M | $420.1M | — | — |
| Total current assets | $1.26B | $1.15B | $997.7M | $988.7M | $964.1M | — | — |
| Property, plant and equipment | $381.9M | $298.3M | $294.3M | $284.2M | $286.3M | — | — |
| Goodwill | $1.95B | $1.65B | $1.59B | $1.53B | $1.53B | $1.55B | — |
| Other intangibles | $673.0M | $488.0M | $499.5M | $517.2M | $521.4M | — | — |
| Total assets | $4.77B | $4.03B | $3.83B | $3.75B | $3.46B | — | — |
| Accounts payable | $360.4M | $318.5M | $306.6M | $316.3M | $345.5M | — | — |
| Short-term debt | $2.4M | $15.0M | $0 | — | — | — | — |
| Total current liabilities | $664.8M | $632.1M | $620.1M | $601.6M | $596.6M | — | — |
| Long-term debt | $1.23B | $1.06B | $1.02B | $1.22B | $0 | — | — |
| Total liabilities | $2.55B | $2.23B | $2.18B | $2.37B | $959.5M | — | — |
| Retained earnings | $800.8M | $597.2M | $350.6M | $159.2M | $0 | — | — |
| Total equity | $2.17B | $1.77B | $1.65B | $1.39B | $2.50B | $2.54B | $2.68B |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $260.6M | $355.4M | $330.5M | $214.4M | $250.7M | $309.2M | — |
| Depreciation and amortisation | $84.1M | $66.8M | $75.0M | $66.0M | $75.9M | $76.6M | — |
| Stock-based compensation | $16.9M | $19.8M | $16.1M | $13.0M | $6.3M | $6.4M | — |
| Capital expenditure | $47.3M | $51.8M | $48.2M | $40.2M | $35.6M | $40.1M | — |
| Investing cash flow | -$479.9M | -$205.7M | -$62.2M | -$184.4M | -$35.3M | -$34.6M | — |
| Financing cash flow | $113.7M | $31.7M | -$219.7M | $7.6M | -$221.6M | -$326.4M | — |
| Dividends paid | $21.9M | $17.0M | $13.3M | $6.1M | $0 | $0 | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001877322-26-000007.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Revenue | — | $1.95B | $2.43B | $2.59B | $2.77B | $2.74B | $2.84B |
| Gross profit | — | $682.5M | $838.0M | $885.5M | $1.02B | $1.04B | $1.05B |
| Net income | — | $157.4M | $238.7M | $228.0M | $211.0M | $264.8M | $226.8M |
Recent filings and events
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Acquisition or disposal completed A purchase or sale of a significant business or asset has closed. Item 2.01
- Unregistered share sale Shares issued outside a registered offering. Dilution, and for a small company often the way it is funded. Item 3.02
- Shareholder rights changed The terms attaching to the shares themselves have changed. Item 3.03
- Charter or fiscal year changed A change to the company's governing documents, or to when its year ends. Item 5.03
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Results announced Item 2.02
- Officer or director change Item 5.02
- Regulation FD disclosure Item 7.01
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 3569
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| NDSN | NORDSON CORP | $17.76B | 37.5x | 3.8% |
| RRX | REGAL REXNORD CORP | $9.85B | 35.2x | -1.6% |
| SYM | Symbotic Inc. | $5.03B | — | 25.7% |
| CHRN | ChronoScale Holdings Corp | $2.15B | — | -15.1% |
| OUST | Ouster, Inc. | $2.14B | — | 52.5% |
| RR | RICHTECH ROBOTICS INC. | $260.2M | — | 19.0% |
| SERV | Serve Robotics Inc. /DE/ | $241.0M | — | 46.2% |
| TAYD | TAYLOR DEVICES, INC. | $180.7M | 21.4x | -10.0% |